Why you should consider KEYTRUDA
for advanced melanoma

Below are a few reasons why you may want to consider treatment with KEYTRUDA for advanced melanoma.

 
Open all
 1 Clinical trial results  

Compared to another immunotherapy,* KEYTRUDA helped more patients live longer. A recent clinical trial compared patients with advanced melanoma who received 10 mg/kg of KEYTRUDA every 2 weeks (279 patients) or 3 weeks (277 patients) with those who received ipilimumab (278 patients). At the time of patient follow-up, 67% (185 of 277 patients) treated with KEYTRUDA every 3 weeks were alive, compared to 60% (166 of 278 patients) treated with ipilimumab; 33% (92 of 277 patients) treated with KEYTRUDA every 3 weeks were not alive at follow-up, compared to 40% (112 of 278 patients) treated with ipilimumab. KEYTRUDA given every 3 weeks was shown to reduce the risk of dying by 31% as compared to ipilimumab.

*KEYTRUDA was compared to ipilimumab.

Compared to chemotherapy, nearly 5 times as many patients on KEYTRUDA saw their tumors shrink. In another clinical trial, 21% (38 of 180 patients) on KEYTRUDA saw their tumors shrink; 19% (34 of 180 patients) saw partial responses and 2% (4 of 180 patients) saw complete responses. This is compared to 4% (8 of 179 patients) on chemotherapy who saw their tumors shrink; all of these patients saw partial responses and no complete responses were seen.

See more clinical trial results
 2 Treatment schedule  

KEYTRUDA is usually given every 3 weeks. Dosing once every 3 weeks means more time between infusions compared to another immunotherapy.

As compared to the usual every 2-week dosing of nivolumab when given by itself.

Learn more about treatment with KEYTRUDA
 3 Immunotherapy treatment  

Immunotherapy is a type of cancer treatment that uses your own immune system to help detect and fight cancer. Instead of attacking cancer cells directly, immunotherapy treatments help your body fight cancer.

KEYTRUDA can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become serious or life-threatening and can lead to death.

See how KEYTRUDA helps fight advanced melanoma
 4 Patient support program  

While taking KEYTRUDA, you can receive 24/7 nurse support by enrolling in KEY+YOU. The KEY+YOU Patient Support Program adds to the care you receive from your health care team.

Sign up for the KEY+YOU Patient Support Program